+ 43 1 7489500
NBS-C BioScience
Our SPR platform provides insight into how biologic molecules, chemical drugs or antibodies induced by vaccines or viral infection interact with viral proteins. Thus, the platform represents a versatile tool box for various applications in pre-clinical, clinical and pharmaceutical anti-viral R&D. We measure binding specificity, kinetics / affinities and biological (neutralizing) potency for a variety of relevant viral molecular targets.
SPR IN VIROLOGY
APPLYING OUR VIRAL SPR PLATFORM, ESTABLISHED TO SUPPORT R&D DURING THE COVID-19 PANDEMIA, WE STUDY THE INTERACTION OF TARGET MOLECULES INVOLVED IN VIRAL PATHOMECHANISM AND DISEASE PROTECTION FOR CLIENTS WORKING ON
- VACCINE DEVELOPMENT
- PASSIVE IMMUNOTHERAPY
- PROTEIN THERAPEUTICS
- ANTIVIRAL AGENTS
- VIRAL DIAGNOSTICS
- POTENCY ASSAY DEVELOPMENT
- EPIDEMIOLOGIC INVESTIGATIONS